Skip to content

Author

S. Appolonova

We have 2 of 86 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Metabolomic phenotype of heart failure in cardio-oncology patients

Heart failure (HF) in cardio-oncology patients during anticancer therapy is usually regarded as an accelerated form of classical HF, which restricts early diagnosis and timely pathogenetically based treatment. Myocardial decompensation in these patients appears to involve distinct molecular mechanisms detectable...

R. Alieva, K. Fozilov, M. Yakhyoeva et al. · 0 citations
Aug 2026

Endothelin-1 as a diagnostic and prognostic biomarker of subclinical anthracycline-induced vascular toxicity in lymphoproliferative diseases patients with low and intermediate cardiotoxic risk

Endothelin-1 is a promising early diagnostic and prognostic biomarker of subclinical anthracycline-induced vascular toxicity in lymphoma patients with low and intermediate CVT-risk receiving anthracycline-based chemotherapy and may facilitate early risk reclassification and optimization of cardio-oncology surveillance...

R. Alieva, K. Fozilov, M. Yakhyoeva et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.